US HB2831 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on April 26 2021 - 25% progression, died in committee
Action: 2021-04-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 26 2021 - 25% progression, died in committee
Action: 2021-04-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes.
Title
Prompt Approval of Safe Generic Drugs Act
Sponsors
| Rep. Nanette Barragan [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-04-27 | House | Referred to the Subcommittee on Health. |
| 2021-04-26 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-04-26 | House | Introduced in House |
Same As/Similar To
HB8588 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/2831/all-info |
| Text | https://www.congress.gov/117/bills/hr2831/BILLS-117hr2831ih.pdf |
